GE HealthCare (GEHC) has delivered the first patient doses of Flyrcado or flurpiridaz F 18 njection, a first-of-its-kind unit dose positron ...

GE HealthCare has delivered the first patient doses of Flyrcadotm (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent ...

MarketThe global single-photon emission computed tomography (SPECT) market is on a steady growth trajectory, with its ...

Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...

GE HealthCare invests $138 million in Cork, Ireland manufacturing facility to address increasing contrast media demand ...

GE HealthCare has announced a $138m investment ... The global demand for iodine-based contrast media, used in computed tomography (CT), X-ray and interventional procedures, is projected to double ...

GE HealthCare has announced a €132m investment ... Global demand for iodine-based contrast media, used in X-Ray, Computed Tomography (CT) and Interventional procedures, is expected to double ...

GE HealthCare Technologies Inc. GEHC recently ... These iodine-based agents are commonly used in X-ray, Computed Tomography (CT) scans, and interventional procedures. With aging populations ...

GE HealthCare Technologies Inc. engages in ... The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems ...